Nov 7, 2022 04:45PM
Aug 12, 2022 07:00AM
May 13, 2022 07:15AM
May 13, 2022 07:15AM
Mar 28, 2022 07:00AM
Mar 28, 2022 07:00AM
Mar 24, 2022 08:00AM HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
Mar 24, 2022 08:00AM
Jan 24, 2022 07:04AM
Jan 24, 2022 07:00AM
Jan 24, 2022 07:00AM
Jan 20, 2022 08:05AM
Jan 20, 2022 08:00AM
Jan 20, 2022 08:00AM HCW Biologics Inc. Announces its Lead Product Candidate Shown to Augment Anti-Tumor Activity and Reduce Side Effects of Chemotherapy Regimens
Jan 19, 2022 08:00AM
Jan 19, 2022 08:00AM
Jan 6, 2022 07:33AM
Jan 6, 2022 07:33AM
Dec 13, 2021 07:31AM
Dec 13, 2021 07:31AM
Nov 12, 2021 07:00AM HCW Biologics Reports Third Quarter Financial Results and Recent Business Highlights
Nov 12, 2021 07:00AM
Oct 28, 2021 07:01AM
Oct 28, 2021 07:00AM
Oct 28, 2021 07:00AM
Oct 27, 2021 07:00AM
Oct 27, 2021 07:00AM
Aug 24, 2021 07:32AM HCW Biologics Showcases Scientific Paper in Molecular Therapy Highlighting Potential of HCW9218 as Novel, Bifunctional Cancer Immunotherapeutic
Aug 24, 2021 07:32AM
Aug 17, 2021 07:35AM
Aug 17, 2021 07:32AM
Aug 17, 2021 07:32AM
Aug 13, 2021 07:10AM
Aug 13, 2021 07:10AM
Jul 22, 2021 04:05PM HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering
Jul 22, 2021 04:05PM
Jul 20, 2021 10:56AM
Jul 20, 2021 04:48AM
Jul 19, 2021 06:39PM
Jul 19, 2021 06:39PM

122,776 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All